China Resources Pharmaceutical Group is an integrated pharmaceutical company that manufactures and distributes medicines, health products, and medical devices. It is listed on the Hong Kong Stock Exchange under stock code 03320.HK and is one of seven core strategic business units within China Resources (Holdings) Co., Ltd. Its manufacturing operations cover chemical drugs, traditional Chinese medicine, biologics, and nutritional health products, and its branded product lines include 999, Dong'e Ejiao, Shuanghe, Jiangzhong, and Boya.
Its pharmaceutical distribution network reaches provinces, municipalities, and autonomous regions across China, alongside a large retail pharmacy network. Distribution customers include secondary and tertiary hospitals and grassroots primary-care medical institutions.

China Resources

China Resources Double-Crane
China Yongxin Pharmaceuticals
yongxinchina.com

Harbin Gloria Pharmaceuticals
China PharmaHub
chnpharmahub.com

Yunnan Baiyao Group
China Grand Pharmaceutical and Healthcare Holdings

China Medical System
cms.net.cn

Shenzhen Salubris Pharmaceuticals

Huadong Medicine
eastchinapharm.com

Nanjing Pharmaceutical
njyy.com

Zhejiang Huahai
en.huahaipharm.com

Jianmin Pharmaceutical Group Co
whjm.com

Luye Pharma Group
luye.cn

Yantai Dongcheng Pharmaceutical Co
dcb-group.com

Hepalink
hepalink.com

Betta Pharmaceuticals
bettapharma.com
Yipinhong Pharmacy

Zuellig Pharma China
zuelligpharma.com

Zhejiang Xianju Pharmaceutical
xjpharma.com
China Resources Pharmaceutical Group's most recent funding round was for CN¥600M (CNY) in January 2023.
As of Jan 10, 2023, China Resources Pharmaceutical Group has disclosed funding of $88.5M (USD).

China Resources Pharmaceutical Group, an integrated pharmaceutical company, manufactures and distributes medicines, health products, and medical devices.